Back
EHRA Premium Access

Gender related differences in management of nonvalvular atrial fibrillation: analysis of multicenter registry (An observational prospective cohort for COmparision study of Drugs for symptom control an

Session: Poster session 2 - Atrial Fibrillation - Clinical and epidemiological aspects
Topic: Clinical and epidemiological aspects (Atrial Fibrillation)
Speaker: Professor J. Lee (Seoul, KR)
Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

About the speaker

Professor Jung Myung Lee

Kyunghee University, Seoul (Korea (Republic of))
0 follower

23 more presentations in this session

Rhythm versus rate control in patients with atrial fibrillation combined with left ventricular systolic dysfunction: a meta-analysis

Speaker: Doctor J. Ahn (Pusan, KR)

Access
Abstract
Thumbnail

Experience using interventional epicardial left atrial appendage ligation

Speaker: Doctor K. Nentwich (Bad Neustadt an der Saale, DE)

Access
Abstract
Thumbnail

Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in patients with atrial fibrillation: from asian perspectives

Speaker: Associate Professor K. Lee (Gwangju, KR)

Access
Abstract
Slides
Thumbnail

Modified application of SAME-TTR score in Asian patients with atrial fibrillation for choice of oral anticoagulants

Speaker: Associate Professor K. Lee (Gwangju, KR)

Access
Abstract
Slides
Thumbnail

Which factors recorded during routine care predict treatment discontinuation of novel oral anticoagulants in patients with non-valvular atrial fibrillation?

Speaker: Doctor C. Lefevre (Rueil-Malmaison, FR)

Access
Abstract
Thumbnail

Access the full session

Poster session 2 - Atrial Fibrillation - Clinical and epidemiological aspects

Speakers: Professor J. Lee, Doctor J. Ahn, Doctor K. Nentwich, Associate Professor K. Lee, Associate Professor K. Lee...
Access
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb